We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WSFS
576
Wilmington Savings Fund Society
Delaware
$372K +$370K +9,502 New
CCT
577
Chemung Canal Trust
New York
$365K +$362K +9,297 New
NB
578
NBT Bank
New York
$359K +$356K +9,136 New
TAM
579
Taurus Asset Management
New York
$359K +$356K +9,153 New
EMG
580
Ellington Management Group
Connecticut
$357K +$354K +9,100 New
JMH
581
J.M. Hartwell
New York
$356K +$354K +9,090 New
AP
582
Appleton Partners
Massachusetts
$350K +$347K +8,918 New
CONA
583
Capital One National Association
New York
$348K +$346K +8,883 New
WSCM
584
Wellington Shields Capital Management
New York
$347K +$345K +8,856 New
SC
585
Schulhoff & Co
Ohio
$342K +$339K +8,714 New
KFC
586
Klingenstein Fields & Co
New York
$341K +$339K +8,700 New
SFG
587
Sather Financial Group
Texas
$341K +$339K +8,700 New
CASB
588
Cape Ann Savings Bank
Massachusetts
$341K +$339K +8,701 New
CC
589
ClearArc Capital
Ohio
$338K +$336K +8,629 New
AA
590
Ancora Advisors
Ohio
$333K +$331K +8,500 New
FCH
591
Freestone Capital Holdings
Washington
$329K +$326K +8,382 New
RT
592
Reliance Trust
Georgia
$326K +$324K +8,327 New
ONB
593
Old National Bancorp
Indiana
$325K +$323K +8,294 New
PTC
594
Philadelphia Trust Company
Pennsylvania
$316K +$314K +8,061 New
RJT
595
Raymond James Trust
Florida
$315K +$313K +8,040 New
SCP
596
Seizert Capital Partners
Michigan
$312K +$310K +7,960 New
FC
597
FIC Capital
New York
$311K +$309K +7,939 New
TSWM
598
Triangle Securities Wealth Management
North Carolina
$310K +$308K +7,918 New
EB
599
Eastern Bank
Massachusetts
$310K +$309K +7,927 New
LI
600
LMCG Investments
Massachusetts
$303K +$301K +7,738 New
22 23
24
25 26

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.